loadpatents
Patent applications and USPTO patent grants for Emancipator; Kenneth.The latest application filed is for "dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancer".
Patent | Date |
---|---|
Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue Grant 11,193,937 - Dolled-Filhart , et al. December 7, 2 | 2021-12-07 |
Dosing Regimen Of Anti-lag3 Antibody And Combination Therapy With Anti-pd-1 Antibody For Treating Cancer App 20210347889 - Abraham; Anson Kunjachan ;   et al. | 2021-11-11 |
Scoring Methods For Anti-pd Therapy Eligibility And Compositions For Performing Same App 20200200759 - Kulangara; Karina ;   et al. | 2020-06-25 |
Scoring methods for anti-PD therapy eligibility and compositions for performing same Grant 10,613,092 - Kulangara , et al. | 2020-04-07 |
Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (pd-l1) In Tumor Tissue App 20180080938 - Dolled-Filhart; Marisa ;   et al. | 2018-03-22 |
Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (pd-l1) In Tumor Tissue App 20160084839 - Dolled-Filhart; Marisa ;   et al. | 2016-03-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.